Filing Details

Accession Number:
0001799191-22-000051
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-11-22 20:07:41
Reporting Period:
2022-11-15
Accepted Time:
2022-11-22 20:07:41
Original Submission Date:
2022-11-17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1799191 Oncology Institute Inc. TOI Services-Offices & Clinics Of Doctors Of Medicine (8011) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1915822 P Matthew Miller C/O The Oncology Institute Inc.
18000 Studebaker Rd, Suite 800
Cerritos CA 90703
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-11-15 577 $2.03 78,034 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This Form 4/A amends and restates the reporting persons Form 4 originally filed on November 17, 2022 in the entirety. This Form 4/A is being filed to correct the reporting persons original Form 4 from Code D to Code S. The sales reported in the Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
  2. Price is the volume weighted average selling price of all sales by the Reporting Person on November 15, 2022 within a one-dollar range. Actual prices ranged from $2.022 to $2.028. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.